Position in PFE
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$915,239
+$144,136 QoQ
Shares Held
32,594
+5.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GM Advisory Group, LLC holds $19,630,085 across 10 Drug Manufacturers - General names. PFE ranks #5 (4.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
10,002 | $9,199,539 | |
| 2 | JNJ |
Johnson & Johnson
|
14,495 | $3,543,157 | |
| 3 | MRK |
Merck & Co., Inc.
|
17,762 | $2,136,590 | |
| 4 | ABBV |
AbbVie Inc.
|
7,400 | $1,609,426 | |
| 5 | PFE |
Pfizer Inc
This page
|
32,594 | $915,239 | |
| 6 | AMGN |
Amgen Inc
|
2,556 | $899,328 | |
| 7 | AZN |
Astrazeneca PLC
|
2,421 | $477,469 | |
| 8 | NVS |
Novartis AG
|
2,102 | $321,080 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $915,239 | 32,594 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $771,103 | 30,968 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $713,261 | 27,993 | Shares | Sole | 2025-11-19 | |
| 2025-06-30 | $748,628 | 30,884 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $771,197 | 30,434 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $764,196 | 28,805 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $835,526 | 28,871 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $859,881 | 30,732 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $991,563 | 35,732 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $873,200 | 30,330 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $627,974 | 18,932 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $770,023 | 20,993 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $850,720 | 20,851 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,033,510 | 20,170 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $888,109 | 20,295 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,027,156 | 19,591 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $953,499 | 18,418 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $929,151 | 15,735 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $655,257 | 15,235 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $596,485 | 15,232 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $551,529 | 15,223 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $459,756 | 12,490 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $371,623 | 10,126 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $243,974 | 7,461 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $245,583 | 7,524 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||